(Q38832613)

6 September 2017

1 reference

title

Toll-like receptors and chronic inflammation in rheumatic diseases: new developments (English)

1 reference

6 September 2017

0 references

1 reference

Luke O'Neill

4

0 references

Charles A. Dinarello

series ordinal

3

object named as

Charles A Dinarello

1 reference

6 September 2017

5

Mihai G Netea

1 reference

6 September 2017

1

Leo A B Joosten

1 reference

6 September 2017

author name string

Shahla Abdollahi-Roodsaz

series ordinal

2

1 reference

6 September 2017

language of work or name

English

0 references

publication date

12 May 2016

1 reference

6 September 2017

number of pages

14

1 reference

Nature Reviews Rheumatology

inferred from page(s)

published in

1 reference

6 September 2017

volume

12

1 reference

6 September 2017

issue

6

1 reference

6 September 2017

page(s)

344-357

1 reference

https://scigraph.springernature.com/pub.10.1038/nrrheum.2016.61

6 September 2017

exact match

0 references

cites work

Pathogen recognition and innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Innate immune recognition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The host defense of Drosophila melanogaster

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Innate immunity: the virtues of a nonclonal system of recognition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The evolution and genetics of innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

IFI16 is an innate immune sensor for intracellular DNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Establishment of dorsal-ventral polarity in the Drosophila embryo: the induction of polarity by the Toll gene product

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The dorsoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Pattern recognition receptors and inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Toll-like receptors in innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Human TLR10 is an anti-inflammatory pattern-recognition receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The evolution of vertebrate Toll-like receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

UNC93B1 mediates differential trafficking of endosomal TLRs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Toll-like receptors and their crosstalk with other innate receptors in infection and immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Intracellular Recognition of Lipopolysaccharide by Toll-like Receptor 4 in Intestinal Epithelial Cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Expression of toll-like receptors 2 and 4 in rheumatoid synovial tissue and regulation by proinflammatory cytokines interleukin-12 and interleukin-18 via interferon-gamma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Dissecting negative regulation of Toll-like receptor signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

New insights into the regulation of TLR signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The Toll-IL-1 receptor adaptor family grows to five members.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Helical assembly in the MyD88–IRAK4–IRAK2 complex in TLR/IL-1R signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

SIGIRR/TIR-8 is an inhibitor of toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Drosophila Toll and IL-1 receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The biology of interleukin 1 and comparison to tumor necrosis factor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice. A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

TNF-induced structural joint damage is mediated by IL-1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Identification of a key pathway required for the sterile inflammatory response triggered by dying cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Discovery of the DIGIRR gene from teleost fish: a novel Toll-IL-1 receptor family member serving as a negative regulator of IL-1 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Mechanisms of disease: a 'DAMP' view of inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcγ receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The pathogenesis of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Increased responsiveness to toll-like receptor 4 stimulation in peripheral blood mononuclear cells from patients with recent onset rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Associations of toll-like receptor (TLR)-4 single nucleotide polymorphisms and rheumatoid arthritis disease progression: an observational cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The microbiome and rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Synovial Epstein-Barr virus infection increases the risk of rheumatoid arthritis in individuals with the shared HLA-DR4 epitope

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Toll-like receptor 2 pathway drives streptococcal cell wall-induced joint inflammation: critical role of myeloid differentiation factor 88

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

T cell dependence of chronic destructive murine arthritis induced by repeated local activation of toll-like receptor–driven pathways: Crucial role of both interleukin-1β and interleukin-17

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Destructive role of myeloid differentiation factor 88 and protective role of TRIF in interleukin-17-dependent arthritis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Arthritogenic properties of double-stranded (viral) RNA.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Prevention of autoimmune disease by induction of tolerance to Toll-like receptor 7

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Investigation of the role of endosomal Toll-like receptors in murine collagen-induced arthritis reveals a potential role for TLR7 in disease maintenance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

A role for fungal {beta}-glucans and their receptor Dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Focused specificity of intestinal TH17 cells towards commensal bacterial antigens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Periodontitis in systemic rheumatic diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Relationship between rheumatoid arthritis and periodontitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Periodontal pathogens directly promote autoimmune experimental arthritis by inducing a TLR2- and IL-1-driven Th17 response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Heightened immune response to autocitrullinated Porphyromonas gingivalis peptidylarginine deiminase: a potential mechanism for breaching immunologic tolerance in rheumatoid arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/macrophages and stimulate tumor necrosis factor alpha production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The Toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Inhibitors of TLR8 reduce TNF production from human rheumatoid synovial membrane cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Blockade of Toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Local interleukin-1-driven joint pathology is dependent on toll-like receptor 4 activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Alternatively spliced EDA-containing fibronectin in synovial fluid as a predictor of rheumatoid joint destruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Glycoprotein 96 perpetuates the persistent inflammation of rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Ligation of TLR7 by rheumatoid arthritis synovial fluid single strand RNA induces transcription of TNFα in monocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Ligation of TLR5 promotes myeloid cell infiltration and differentiation into mature osteoclasts in rheumatoid arthritis and experimental arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Infections as triggers and complications of systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The cryptic interplay between systemic lupus erythematosus and infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Toll-like receptors in systemic lupus erythematosus: potential for personalized treatment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Ro60 requires Y3 RNA for cell surface exposure and inflammation associated with cardiac manifestations of neonatal lupus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Regulation of autoreactive B cell responses to endogenous TLR ligands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Role of TLR9 in anti-nucleosome and anti-DNA antibody production in lpr mutation-induced murine lupus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Update on gout: new therapeutic strategies and options

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Uric acid as a danger signal in gout and its comorbidities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Enhanced interleukin-1β production of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Association of TLR4 Gene rs2149356 polymorphism with primary gouty arthritis in a case-control study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Gout-associated uric acid crystals activate the NALP3 inflammasome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Cutting edge: NF-kappaB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

MyD88 plays a unique role in host defense but not arthritis development in Lyme disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

A long-term five-year randomized controlled trial of hydroxychloroquine, sodium aurothiomalate, auranofin and penicillamine in the treatment of patients with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

α-TLR2 antibody attenuates the Aβ-mediated inflammatory response in microglia through enhanced expression of SIGIRR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Randomized, double-blind, placebo-controlled, dose-escalating phase I, healthy subjects study of intravenous OPN-305, a humanized anti-TLR2 antibody

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Citrullination enhances the pro-inflammatory response to fibrin in rheumatoid arthritis synovial fibroblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Emerging role of endosomal toll-like receptors in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

A novel antagonist of Toll-like receptors 7, 8 and 9 suppresses lupus disease-associated parameters in NZBW/F1 mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and the B cell receptor by regulating calcium and calmodulin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The receptor TREML4 amplifies TLR7-mediated signaling during antiviral responses and autoimmunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Small-molecule inhibitors of the TLR3/dsRNA complex

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Inhibition of TLR2 signaling by small molecule inhibitors targeting a pocket within the TLR2 TIR domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

RDP58, a novel immunomodulatory peptide, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalomyelitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Pharmacological inhibition of TLR9 activation blocks autoantibody production in human B cells from SLE patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Interleukin-1 receptor associated kinase inhibitors: potential therapeutic agents for inflammatory- and immune-related disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The phosphatase SRC homology region 2 domain-containing phosphatase-1 is an intrinsic central regulator of dendritic cell function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

LRRK2 is involved in the IFN-gamma response and host response to pathogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Identification and characterization of a unique leucine-rich repeat protein (LRRC33) that inhibits Toll-like receptor-mediated NF-κB activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

The history of Toll-like receptors - redefining innate immunity.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRRHEUM.2016.61

Fecal microbiota in early rheumatoid arthritis

31 March 2020

1 reference

12 December 2020

Expression of myeloid related proteins (MRP) 8 and 14 and the MRP8/14 heterodimer in rheumatoid arthritis synovial membrane

1 reference

12 December 2020

Acute inflammation and a Shwartzman-like reaction induced by interleukin-1 and tumor necrosis factor. Synergistic action of the cytokines in the induction of inflammation and microvascular injury

1 reference

12 December 2020

Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity

1 reference

12 December 2020

Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1.

1 reference

12 December 2020

RDP-58 (SangStat Medical).

1 reference

12 December 2020

Amino acids conserved in interleukin-1 receptors (IL-1Rs) and the Drosophila toll protein are essential for IL-1R signal transduction.

1 reference

12 December 2020

Internalization and nuclear localization of interleukin 1 are not sufficient for function

1 reference

12 December 2020

Recombinant interleukin 1 and tumor necrosis factor acting in synergy to release thromboxane, 6-KETO-PGF1 alpha and PGE2 by human neutrophils

1 reference

12 December 2020

Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity.

1 reference

12 December 2020

XToll, a recombinant chaperonin 10 as an anti-inflammatory immunomodulator

1 reference

12 December 2020

MicroRNAs: new regulators of Toll-like receptor signalling pathways

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2016.61

1 reference

Dimensions Publication ID

6 September 2017

1038757219

0 references

1 reference